Hepatitis E virus infection

Clinical Microbiology Reviews

Volumn 27, Issue 1, 2014, Pages 116-138

  Kamar, Nassim ^a,b,c   Dalton, Harry R ^d   Abravanel, Florence ^b,c   Izopet, Jacques ^b,c  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E VACCINE; IMMUNOGLOBULIN M ANTIBODY; PEGINTERFERON; RIBAVIRIN;

ANTIVIRAL THERAPY; CHRONIC HEPATITIS; DISEASE COURSE; ENZYME IMMUNOASSAY; HEMATOLOGIC DISEASE; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOAFFINITY CHROMATOGRAPHY; KIDNEY INJURY; LIMIT OF DETECTION; LIVER DISEASE; MORBIDITY; MULTICENTER STUDY (TOPIC); NEUROLOGIC DISEASE; ORGAN TRANSPLANTATION; PANCREATITIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY; RAPID TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; VIRUS TRANSMISSION;

CHRONIC DISEASE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE RESERVOIRS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS;

EID: 84891674329     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00057-13     Document Type: Review

References (306)

1. Khuroo MS. 1980. Chronic liver disease after non-A, non-B hepatitis. Lancet ii:860-861.
2. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. 1980. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet ii:876-879.
3. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. 1983. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20:23-31. http://dx.doi.org/10.1159/000149370.
4. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, Bradley DW. 1990. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247:1335-1339. http://dx.doi.org/10.1126/science.2107574.
5. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131. http: //dx.doi.org/10.1016/0042-6822(91)90760-9.
6. Yarbough PO, Tam AW, Fry KE, Krawczynski K, McCaustland KA, Bradley DW, Reyes GR. 1991. Hepatitis E virus: identification of typecommon epitopes. J. Virol. 65:5790-5797.
7. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, Thacker BJ, Emerson SU. 1997. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U. S. A. 94:9860-9865. http://dx.doi.org/10.1073/pnas.94.18.9860.
8. Lu L, Li C, Hagedorn CH. 2006. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16:5-36. http://dx.doi.org/10.1002/rmv.482.
9. Hoofnagle JH, Nelson KE, Purcell RH. 2012. Hepatitis E. N. Engl. J. Med. 367:1237-1244. http://dx.doi.org/10.1056/NEJMra1204512.
10. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. 2012. Hepatitis E. Lancet 379:2477-2488. http://dx.doi.org /10.1016/S0140-6736(11)61849-7.
11. Purcell RH, Emerson SU. 2008. Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48:494-503. http://dx.doi.org/10.1016/j.jhep.2007.12.008.
12. Teshale EH, Hu DJ, Holmberg SD. 2010. The two faces of hepatitis E virus. Clin. Infect. Dis. 51:328-334. http://dx.doi.org/10.1086/653943.
13. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. 2008. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 358:811-817. http://dx.doi.org/10.1056/NEJMoa0706992.
14. Labrique A, Kuniholm MH, Nelson K. 2010. The global impact of hepatitis E: new horizons for an emerging virus, p 53-93. In Scheld WM, Grayson ML, Hughes JM (ed), Emerging infections, 9th ed. ASM Press, Washington, DC.
15. Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R. 2013. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J. Viral Hepat. 20:e138-e140. http://dx.doi.org/10.1111/jvh.12027.
16. Dalton HR, Thurairajah PH, Fellows HJ, Hussaini HS, Mitchell J, Bendall R, Banks M, Ijaz S, Teo CG, Levine DF. 2007. Autochthonous hepatitis E in southwest England. J. Viral Hepat. 14:304-309. http://dx.doi.org/10.1111/j.1365-2893.2006.00800.x.
17. Tei S, Kitajima N, Takahashi K, Mishiro S. 2003. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362:371-373. http://dx.doi.org/10.1016/S0140-6736(03)14025-1.
18. Dalton HR, Bendall R, Ijaz S, Banks M. 2008. Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 8:698-709. http://dx.doi.org/10.1016/S1473-3099(08)70255-X.
19. Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, Schroeder B, Croxson MC, Garkavenko O. 2007. Hepatitis E in New Zealand. J. Gastroenterol. Hepatol. 22:1236-1240. http://dx.doi.org/10.1111/j.1440-1746.2007.04894.x.
20. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, Banks M, Ijaz S, Bendall RP. 2008. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 20:784-790. http://dx.doi.org/10.1097/MEG.0b013e3282f5195a.
21. Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. 2011. Hepatitis E virus and neurologic disorders. Emerg. Infect. Dis. 17:173-179. http: //dx.doi.org/10.3201/eid1702.100856.
22. Mizuo H, Yazaki Y, Sugawara K, Tsuda F, Takahashi M, Nishizawa T, Okamoto H. 2005. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J. Med. Virol. 76:341-349. http://dx.doi.org/10.1002/jmv.20364.
23. Jeblaoui A, Haim-Boukobza S, Marchadier E, Mokhtari C, Roque-Afonso AM. 2013. Genotype 4 hepatitis E virus in France: an autochthonous infection with a more severe presentation. Clin. Infect. Dis. 57: e122-e126. http://dx.doi.org/10.1093/cid/cit291.
24. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP. 2007. The role of hepatitis E virus testing in drug-induced liver injury. Aliment. Pharmacol. Ther. 26:1429-1435. http://dx.doi.org/10.1111/j.1365-2036.2007.03504.x.
25. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH. 2011. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 141:1665-1672. http://dx.doi.org/10.1053/j.gastro.2011.07.051.
26. Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K. 2012. Review of the neurological manifestations of hepatitis E infection. Ann. Hepatol. 11:618-622.
27. Chalupa P, Holub M. 2010. Jaundice complicated by an atypical form of Guillain-Barre syndrome. J. Clin. Virol. 49:229-230. http://dx.doi.org /10.1016/j.jcv.2010.07.017.
28. Cronin S, McNicholas R, Kavanagh E, Reid V, O'Rourke K. 2011. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir. J. Med. Sci. 180:255-257. http://dx.doi.org/10.1007 /s11845-010-0635-7.
29. Despierres LA, Kaphan E, Attarian S, Cohen-Bacrie S, Pelletier J, Pouget J, Motte A, Charrel R, Gerolami R, Colson P. 2011. Neurologic disorders and hepatitis E, France, 2010. Emerg. Infect. Dis. 17:1510-1512. http://dx.doi.org/10.3201/eid1708.102028.
30. Kamani P, Baijal R, Amarapurkar D, Gupte P, Patel N, Kumar P, Agal S. 2005. Guillain-Barre syndrome associated with acute hepatitis E. Indian J. Gastroenterol. 24:216.
31. Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, Delwaide J. 2009. Guillain-Barre syndrome following hepatitis E. World J. Gastroenterol. 15:1645-1647. http://dx.doi.org/10.3748/wjg.15.1645.
32. Maddukuri VC, Russo MW, Ahrens WA, Emerson SU, Engle RE, Purcell RH, Thompson EB, Bonkovsky HL. 2013. Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient. Dig. Dis. Sci. 58:2413-2416. http://dx.doi.org /10.1007/s10620-013-2628-7.
33. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. 2012. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 40:323-326. http://dx.doi.org/10.1007/s15010-011-0185-6.
34. Sood A, Midha V, Sood N. 2000. Guillain-Barre syndrome with acute hepatitis E. Am. J. Gastroenterol. 95:3667-3668. http://dx.doi.org/10.1111/j.1572-0241.2000.03409.x.
35. Tse AC, Cheung RT, Ho SL, Chan KH. 2012. Guillain-Barre syndrome associated with acute hepatitis E infection. J. Clin. Neurosci. 19:607-608. http://dx.doi.org/10.1016/j.jocn.2011.06.024.
36. Dixit VK, Abhilash VB, Kate MP, Jain AK. 2006. Hepatitis E infection with Bell's palsy. J. Assoc. Physicians India 54:418.
37. Fong F, Illahi M. 2009. Neuralgic amyotrophy associated with hepatitis E virus. Clin. Neurol. Neurosurg. 111:193-195. http://dx.doi.org/10.1016/j.clineuro.2008.09.005.
38. Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. 2010. The entire genome sequence of hepatitis E virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand. J. Infect. Dis. 42:395-400. http://dx.doi.org/10.3109 /00365540903496551.
39. Mandal K, Chopra N. 2006. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 43:365-366.
40. Kejariwal D, Roy S, Sarkar N. 2001. Seizure associated with acute hepatitis E. Neurology 57:1935. http://dx.doi.org/10.1212/WNL.57.10.1935.
41. Del Bello A, Arne-Bes MC, Lavayssiere L, Kamar N. 2012. Hepatitis E virus-induced severe myositis. J. Hepatol. 57:1152-1153. http://dx.doi.org/10.1016/j.jhep.2012.05.010.
42. Kamar N, Izopet J, Cintas P, Garrouste C, Uro-Coste E, Cointault O, Rostaing L. 2010. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am. J. Transplant. 10: 1321-1324. http://dx.doi.org/10.1111/j.1600-6143.2010.03068.x.
43. Kamar N, Mansuy JM, Esposito L, Legrand-Abravanel F, Peron JM, Durand D, Rostaing L, Izopet J. 2005. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am. J. Kidney Dis. 45:193-196. http://dx.doi.org/10.1053 /j.ajkd.2004.09.006.
44. Kamar N, Weclawiack H, Guilbeaud-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. 2012. Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation 93:617-623. http://dx.doi.org/10.1097/TP.0b013e318245f14c.
45. Ali G, Kumar M, Bali SK, Wadhwa WB. 2001. Hepatitis E associated immune thrombocytopaenia and membranous glomerulonephritis. Indian J. Nephrol. 11:70-72.
46. Bhagat S, Wadhawan M, Sud R, Arora A. 2008. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas 36:424-427. http://dx.doi.org/10.1097/MPA.0b013e31815d9d53.
47. Deniel C, Coton T, Brardjanian S, Guisset M, Nicand E, Simon F. 2011. Acute pancreatitis: a rare complication of acute hepatitis E. J. Clin. Virol. 51:202-204. http://dx.doi.org/10.1016/j.jcv.2011.04.009.
48. Sinha S, Jha R, Lakhtakia S, Narayan G. 2003. Acute pancreatitis following kidney transplantation-role of viral infections. Clin. Transplant. 17:32-36. http://dx.doi.org/10.1034/j.1399-0012.2003.02041.x.
49. Thapa R, Biswas B, Mallick D, Ghosh A. 2009. Acute pancreatitis-complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin. Pediatr. (Phila.) 48:199-201. http://dx.doi.org/10.1177/0009922808327107.
50. Colson P, Payraudeau E, Leonnet C, De Montigny S, Villeneuve L, Motte A, Tamalet C. 2008. Severe thrombocytopenia associated with acute hepatitis E virus infection. J. Clin. Microbiol. 46:2450-2452. http: //dx.doi.org/10.1128/JCM.02295-07.
51. Fourquet E, Mansuy JM, Bureau C, Recher C, Vinel JP, Izopet J, Peron JM. 2010. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J. Clin. Virol. 48:73-74. http://dx.doi.org/10.1016/j.jcv.2010.02.016.
52. Shah SA, Lal A, Idrees M, Hussain A, Jeet C, Malik FA, Iqbal Z, Rehman H. 2012. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J. Clin. Virol. 54:96-97. http://dx.doi.org/10.1016/j.jcv.2012.02.002.
53. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. 2012. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 55:988-997. http://dx.doi.org/10.1002/hep.25505.
54. Labrique AB, Sikder SS, Krain LJ, West KP, Jr, Christian P, Rashid M, Nelson KE. 2012. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg. Infect. Dis. 18:1401-1404. http://dx.doi.org/10.3201 /eid1809.120241.
55. Khuroo MS, Kamili S, Jameel S. 1995. Vertical transmission of hepatitis E virus. Lancet 345:1025-1026. http://dx.doi.org/10.1016/S0140-6736(95) 90761-0.
56. Anty R, Ollier L, Peron JM, Nicand E, Cannavo I, Bongain A, Giordanengo V, Tran A. 2012. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France. J. Clin. Virol. 54:76-78. http://dx.doi.org/10.1016/j.jcv.2012.01.016.
57. Andersson MI, Hughes J, Gordon FH, Ijaz S, Donati M. 2008. Of pigs and pregnancy. Lancet 372:1192. http://dx.doi.org/10.1016/S0140-6736(08)61486-5.
58. Thoden J, Venhoff N, Miehle N, Klar M, Huzly D, Panther E, Jilg N, Kunze M, Warnatz K. 2008. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 22:909-910. http://dx.doi.org/10.1097/QAD.0b013e3282f7cb9a.
59. Navaneethan U, Al Mohajer M, Shata MT. 2008. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28:1190-1199. http://dx.doi.org/10.1111/j.1478-3231.2008.01840.x.
60. Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. 2013. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol. Res. 43:826-835. http://dx.doi.org/10.1111/hepr.12028.
61. Prabhu SB, Gupta P, Durgapal H, Rath S, Gupta SD, Acharya SK, Panda SK. 2011. Study of cellular immune response against hepatitis E virus (HEV). J. Viral Hepat. 18:587-594. http://dx.doi.org/10.1111/j.1365-2893.2010.01338.x.
62. Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. 2011. High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. J. Hepatol. 54:1107-1113. http://dx.doi.org/10.1016/j.jhep.2010.08.037.
63. Prusty BK, Hedau S, Singh A, Kar P, Das BC. 2007. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol. Med. 13:518-526. http: //dx.doi.org/10.2119/2007-00055.Prusty.
64. Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. 2007. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J. Gastroenterol. Hepatol. 22:676-682. http://dx.doi.org/10.1111/j.1440-1746.2007.04913.x.
65. Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. 2005. Immunological alterations in pregnant women with acute hepatitis E. J. Gastroenterol. Hepatol. 20:1094-1101. http://dx.doi.org/10.1111/j.1440-1746.2005.03875.x.
66. Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. 2008. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am. J. Gastroenterol. 103:2495-2501. http://dx.doi.org/10.1111/j.1572-0241.2008.02032.x.
67. Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. 2013. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J. Med. Virol. 85:620-626. http: //dx.doi.org/10.1002/jmv.23508.
68. Mishra N, Walimbe AM, Arankalle VA. 2013. Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients. Virus Genes 46:47-53. http://dx.doi.org/10.1007/s11262-012-0833-7.
69. Gad YZ, Mousa N, Shams M, Elewa A. 2011. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J. Transfus. Sci. 5:136-139. http://dx.doi.org/10.4103/0973-6247.83238.
70. Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, Kumar Panda S. 2007. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J. Hepatol. 46:387-394. http://dx.doi.org/10.1016/j.jhep.2006.09.016.
71. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. 2007. Locally acquired hepatitis E in chronic liver disease. Lancet 369:1260. http://dx.doi.org/10.1016/S0140-6736(07)60595-9.
72. Peron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, Dupuis E, Izopet J, Vinel JP. 2007. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J. Viral Hepat. 14:298-303. http://dx.doi.org/10.1111/j.1365-2893.2007.00858.x.
73. Dalton HR, Bendall RP, Pritchard C, Henley W, Melzer D. 2010. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol. Infect. 138:174-182. http://dx.doi.org /10.1017/S0950268809990306.
74. Nanji AA, French SW. 1985. Relationship between pork consumption and cirrhosis. Lancet i:681-683.
75. Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. 1992. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. U. S. A. 89:8259-8263. http://dx.doi.org/10.1073 /pnas.89.17.8259.
76. Li TC, Yamakawa Y, Suzuki K, Tatsumi M, Razak MA, Uchida T, Takeda N, Miyamura T. 1997. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71:7207-7213.
77. He S, Miao J, Zheng Z, Wu T, Xie M, Tang M, Zhang J, Ng MH, Xia N. 2008. Putative receptor-binding sites of hepatitis E virus. J. Gen. Virol. 89:245-249. http://dx.doi.org/10.1099/vir.0.83308-0.
78. Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. 2009. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83:12714-12724. http://dx.doi.org/10.1128/JVI.00717-09.
79. Xing L, Wang JC, Li TC, Yasutomi Y, Lara J, Khudyakov Y, Schofield D, Emerson SU, Purcell RH, Takeda N, Miyamura T, Cheng RH. 2011. Spatial configuration of hepatitis E virus antigenic domain. J. Virol. 85: 1117-1124. http://dx.doi.org/10.1128/JVI.00657-10.
80. Guu TS, Liu Z, Ye Q, Mata DA, Li K, Yin C, Zhang J, Tao YJ. 2009. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. U. S. A. 106: 12992-12997. http://dx.doi.org/10.1073/pnas.0904848106.
81. Tang X, Yang C, Gu Y, Song C, Zhang X, Wang Y, Zhang J, Hew CL, Li S, Xia N, Sivaraman J. 2011. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc. Natl. Acad. Sci. U. S. A. 108:10266-10271. http://dx.doi.org/10.1073/pnas.1101309108.
82. Xing L, Li TC, Mayazaki N, Simon MN, Wall JS, Moore M, Wang CY, Takeda N, Wakita T, Miyamura T, Cheng RH. 2010. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J. Biol. Chem. 285:33175-33183. http://dx.doi.org/10.1074 /jbc.M110.106336.
83. Yamashita T, Mori Y, Miyazaki N, Cheng RH, Yoshimura M, Unno H, Shima R, Moriishi K, Tsukihara T, Li TC, Takeda N, Miyamura T, Matsuura Y. 2009. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. U. S. A. 106:12986-12991. http://dx.doi.org/10.1073/pnas.0903699106.
84. Meng J, Dai X, Chang JC, Lopareva E, Pillot J, Fields HA, Khudyakov YE. 2001. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288:203-211. http://dx.doi.org/10.1006/viro.2001.1093.
85. Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH. 2010. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J. Virol. 84:9059-9069. http://dx.doi.org /10.1128/JVI.00593-10.
86. Yamada K, Takahashi M, Hoshino Y, Takahashi H, Ichiyama K, Nagashima S, Tanaka T, Okamoto H. 2009. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol. 90:1880-1891. http://dx.doi.org/10.1099/vir.0.010561-0.
87. Graff J, Torian U, Nguyen H, Emerson SU. 2006. A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 80:5919-5926. http://dx.doi.org/10.1128/JVI.00046-06.
88. Perttila J, Spuul P, Ahola T. 2013. Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1. J. Gen. Virol. 94:807-816. http://dx.doi.org/10.1099/vir.0.049577-0.
89. Williams TP, Kasorndorkbua C, Halbur PG, Haqshenas G, Guenette DK, Toth TE, Meng XJ. 2001. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. Clin. Microbiol. 39:3040-3046. http://dx.doi.org/10.1128/JCM.39.9.3040-3046.2001.
90. Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, Jirintai Mizuo H, Yazaki Y, Takagi T, Azuma M, Kusano E, Isoda N, Sugano K, Okamoto H. 2010. Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence ofHEVantibodies: characterization of HEV virions in blood circulation. J. Clin. Microbiol. 48:1112-1125. http://dx.doi.org/10.1128/JCM.02002-09.
91. Tanaka T, Takahashi M, Kusano E, Okamoto H. 2007. Development and evaluation of an efficient cell-culture system for hepatitis E virus. J. Gen. Virol. 88:903-911. http://dx.doi.org/10.1099/vir.0.82535-0.
92. Tanaka T, Takahashi M, Takahashi H, Ichiyama K, Hoshino Y, Nagashima S, Mizuo H, Okamoto H. 2009. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HEJF5/ 15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 47:1906-1910. http://dx.doi.org/10.1128/JCM.00629-09.
93. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, Bendall RP, Keane FE, Purcell RH, Emerson SU. 2011. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc. Natl. Acad. Sci. U. S. A. 108:2438-2443. http://dx.doi.org/10.1073/pnas.1018878108.
94. Shukla P, Nguyen HT, Faulk K, Mather K, Torian U, Engle RE, Emerson SU. 2012. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J. Virol. 86:5697-5707. http://dx.doi.org/10.1128/JVI.00146-12.
95. Rogee S, Talbot N, Caperna T, Bouquet J, Barnaud E, Pavio N. 2013. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J. Gen. Virol. 94:549-558. http://dx.doi.org/10.1099/vir.0.049858-0.
96. Tsarev SA, Tsareva TS, Emerson SU, Yarbough PO, Legters LJ, Moskal T, Purcell RH. 1994. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J. Med. Virol. 43:135-142. http://dx.doi.org/10.1002/jmv.1890430207.
97. Tsarev SA, Emerson SU, Tsareva TS, Yarbough PO, Lewis M, Govindarajan S, Reyes GR, Shapiro M, Purcell RH. 1993. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J. Infect. Dis. 167:1302-1306. http://dx.doi.org/10.1093/infdis/167.6.1302.
98. Liu P, Bu QN, Wang L, Han J, Du RJ, Lei YX, Ouyang YQ, Li J, Zhu YH, Lu FM, Zhuang H. 2013. Transmission of hepatitis E virus from rabbits to cynomolgus macaques. Emerg. Infect. Dis. 19:559-565. http: //dx.doi.org/10.3201/eid1904.120827.
99. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. 2000. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 356: 1081-1082. http://dx.doi.org/10.1016/S0140-6736(00)02737-9.
100. Nicand E, Armstrong GL, Enouf V, Guthmann JP, Guerin JP, Caron M, Nizou JY, Andraghetti R. 2005. Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J. Med. Virol. 77:519-521. http://dx.doi.org/10.1002/jmv.20487.
101. Ippagunta SK, Naik S, Sharma B, Aggarwal R. 2007. Presence of hepatitis E virus in sewage in northern India: frequency and seasonal pattern. J. Med. Virol. 79:1827-1831. http://dx.doi.org/10.1002/jmv.21017.
102. Izopet J, Dubois M, Bertagnoli S, Lhomme S, Marchandeau S, Boucher S, Kamar N, Abravanel F, Guerin JL. 2012. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg. Infect. Dis. 18:1274-1281. http://dx.doi.org/10.3201 /eid1808.120057.
103. Sonoda H, Abe M, Sugimoto T, Sato Y, Bando M, Fukui E, Mizuo H, Takahashi M, Nishizawa T, Okamoto H. 2004. Prevalence of hepatitis E virus (HEV) infection in wild boars and deer and genetic identification of a genotype 3 HEV from a boar in Japan. J. Clin. Microbiol. 42:5371-5374. http://dx.doi.org/10.1128/JCM.42.11.5371-5374.2004.
104. Pavio N, Meng XJ, Renou C. 2010. Zoonotic hepatitis E: animal reservoirs and emerging risks. Vet. Res. 41:46. http://dx.doi.org/10.1051 /vetres/2010018.
105. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. 2011. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 6:e22673. http://dx.doi.org/10.1371/journal.pone.0022673.
106. Colson P, Romanet P, Moal V, Borentain P, Purgus R, Benezech A, Motte A, Gerolami R. 2012. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg. Infect. Dis. 18:1361-1364. http://dx.doi.org/10.3201/eid1808.111827.
107. Garbuglia AR, Scognamiglio P, Petrosillo N, Mastroianni CM, Sordillo P, Gentile D, La Scala P, Girardi E, Capobianchi MR. 2013. Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg. Infect. Dis. 19:110-114. http://dx.doi.org/10.3201/eid1901.120983.
108. Tesse S, Lioure B, Fornecker L, Wendling MJ, Stoll-Keller F, Bigaillon C, Nicand E. 2012. Circulation of genotype 4 hepatitis E virus in Europe: first autochthonous hepatitis E infection in France. J. Clin. Virol. 54:197-200. http://dx.doi.org/10.1016/j.jcv.2012.02.007.
109. Johne R, Plenge-Bonig A, Hess M, Ulrich RG, Reetz J, Schielke A. 2010. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J. Gen. Virol. 91:750-758. http://dx.doi.org/10.1099/vir.0.016584-0.
110. Raj VS, Smits SL, Pas SD, Provacia LB, Moorman-Roest H, Osterhaus AD, Haagmans BL. 2012. Novel hepatitis E virus in ferrets, the Netherlands. Emerg. Infect. Dis. 18:1369-1370. http://dx.doi.org/10.3201 /eid1808.111659.
111. Nakamura M, Takahashi K, Taira K, Taira M, Ohno A, Sakugawa H, Arai M, Mishiro S. 2006. Hepatitis E virus infection in wild mongooses of Okinawa, Japan: demonstration of anti-HEV antibodies and a fullgenome nucleotide sequence. Hepatol. Res. 34:137-140. http://dx.doi.org/10.1016/j.hepres.2005.10.010.
112. Drexler JF, Seelen A, Corman VM, Fumie Tateno A, Cottontail V, Melim Zerbinati R, Gloza-Rausch F, Klose SM, Adu-Sarkodie Y, Oppong SK, Kalko EK, Osterman A, Rasche A, Adam A, Muller MA, Ulrich RG, Leroy EM, Lukashev AN, Drosten C. 2012. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J. Virol. 86:9134-9147. http://dx.doi.org /10.1128/JVI.00800-12.
113. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. 2010. Pig liver sausage as a source of hepatitis E virus transmission to humans. J. Infect. Dis. 202:825-834. http://dx.doi.org/10.1086/655898.
114. Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ. 2007. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J. Gen. Virol. 88:912-917. http://dx.doi.org/10.1099/vir.0.82613-0.
115. Matsuda H, Okada K, Takahashi K, Mishiro S. 2003. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J. Infect. Dis. 188:944. http://dx.doi.org/10.1086/378074.
116. Yazaki Y, Mizuo H, Takahashi M, Nishizawa T, Sasaki N, Gotanda Y, Okamoto H. 2003. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 84:2351-2357. http://dx.doi.org /10.1099/vir.0.19242-0.
117. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, Jilg W, Stark K. 2008. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J. Infect. Dis. 198:1732-1741. http://dx.doi.org/10.1086/593211.
118. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. 2010. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J. Infect. Dis. 202:835-844. http://dx.doi.org/10.1086/655899.
119. Emerson SU, Arankalle VA, Purcell RH. 2005. Thermal stability of hepatitis E virus. J. Infect. Dis. 192:930-933. http://dx.doi.org/10.1086 /432488.
120. Barnaud E, Rogee S, Garry P, Rose N, Pavio N. 2012. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl. Environ. Microbiol. 78:5153-5159. http://dx.doi.org/10.1128/AEM.00436-12.
121. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. 2002. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J. Clin. Microbiol. 40:117-122. http://dx.doi.org/10.1128/JCM.40.1.117-122.2002.
122. Colson P, Borentain P, Motte A, Lagrange X, Kaba M, Henry M, Tamalet C, Gerolami R. 2007. First human cases of hepatitis E infection with genotype 3c strains. J. Clin. Virol. 40:318-320. http://dx.doi.org/10.1016/j.jcv.2007.08.002.
123. Renou C, Cadranel JF, Bourliere M, Halfon P, Ouzan D, Rifflet H, Carenco P, Harafa A, Bertrand JJ, Boutrouille A, Muller P, Igual JP, Decoppet A, Eloit M, Pavio N. 2007. Possible zoonotic transmission of hepatitis E from pet pig to its owner. Emerg. Infect. Dis. 13:1094-1096. http://dx.doi.org/10.3201/eid1307.070063.
124. Galiana C, Fernandez-Barredo S, Garcia A, Gomez MT, Perez-Gracia MT. 2008. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am. J. Trop. Med. Hyg. 78:1012-1015.
125. Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S, Girones R. 2003. Hepatitis E virus epidemiology in industrialized countries. Emerg. Infect. Dis. 9:448-454. http://dx.doi.org/10.3201/eid0904.020351.
126. Kasorndorkbua C, Opriessnig T, Huang FF, Guenette DK, Thomas PJ, Meng XJ, Halbur PG. 2005. Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but evidence of water contamination is lacking. Appl. Environ. Microbiol. 71:7831-7837. http://dx.doi.org/10.1128/AEM.71.12.7831-7837.2005.
127. La Rosa G, Pourshaban M, Iaconelli M, Vennarucci VS, Muscillo M. 2010. Molecular detection of hepatitis E virus in sewage samples. Appl. Environ. Microbiol. 76:5870-5873. http://dx.doi.org/10.1128/AEM.00336-10.
128. McCreary C, Martelli F, Grierson S, Ostanello F, Nevel A, Banks M. 2008. Excretion of hepatitis E virus by pigs of different ages and its presence in slurry stores in the United Kingdom. Vet. Rec. 163:261-265. http: //dx.doi.org/10.1136/vr.163.9.261.
129. Rutjes SA, Lodder WJ, Lodder-Verschoor F, van den Berg HH, Vennema H, Duizer E, Koopmans M, de Roda Husman AM. 2009. Sources of hepatitis E virus genotype 3 in The Netherlands. Emerg. Infect. Dis. 15:381-387. http://dx.doi.org/10.3201/eid1503.071472.
130. Song YJ, Jeong HJ, Kim YJ, Lee SW, Lee JB, Park SY, Song CS, Park HM, Choi IS. 2010. Analysis of complete genome sequences of swine hepatitis E virus and possible risk factors for transmission of HEV to humans in Korea. J. Med. Virol. 82:583-591. http://dx.doi.org/10.1002 /jmv.21730.
131. Crossan C, Baker PJ, Craft J, Takeuchi Y, Dalton HR, Scobie L. 2012. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg. Infect. Dis. 18:2085-2087. http://dx.doi.org/10.3201/eid1812.120924.
132. Said B, Ijaz S, Kafatos G, Booth L, Thomas HL, Walsh A, Ramsay M, Morgan D. 2009. Hepatitis E outbreak on cruise ship. Emerg. Infect. Dis. 15:1738-1744. http://dx.doi.org/10.3201/eid1511.091094.
133. Arankalle VA, Chobe LP. 2000. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang. 79:72-74. http://dx.doi.org/10.1046/j.1423-0410.2000.7920072.x.
134. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, Teo CG. 2006. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus. Med. 16:79-83. http://dx.doi.org/10.1111/j.1365-3148.2006.00652.x.
135. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. 2007. Transfusion-associated hepatitis E, France. Emerg. Infect. Dis. 13:648-649. http://dx.doi.org/10.3201/eid1304.061387.
136. Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, Teillet L, Roque-Afonso AM. 2012. Transfusiontransmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J. Hepatol. 57:1374-1378. http://dx.doi.org/10.1016/j.jhep.2012.08.001.
137. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, Takahashi K, Mishiro S, Imai M, Takeda N, Ikeda H. 2004. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44:934-940. http://dx.doi.org/10.1111/j.1537-2995.2004.03300.x.
138. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, Kato T, Nishimori H, Tsuji K, Maguchi H, Yoshida J, Maekubo H, Mishiro S, Ikeda H. 2008. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48:1368-1375. http://dx.doi.org/10.1111/j.1537-2995.2008.01722.x.
139. Adlhoch C, Kaiser M, Pauli G, Koch J, Meisel H. 2009. Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang. 97:303-308. http://dx.doi.org/10.1111/j.1423-0410.2009.01211.x.
140. Baylis SA, Koc O, Nick S, Blumel J. 2012. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang. 102:182-183. http://dx.doi.org/10.1111/j.1423-0410.2011.01527.x.
141. Ijaz S, Szypulska R, Tettmar KI, Kitchen A, Tedder RS. 2012. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang. 102:272. http://dx.doi.org/10.1111/j.1423-0410.2011.01554.x.
142. Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. 2012. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 103:89-90. http://dx.doi.org/10.1111/j.1423-0410.2011.01583.x.
143. Vollmer T, Diekmann J, Johne R, Eberhardt M, Knabbe C, Dreier J. 2012. Novel approach for detection of hepatitis E virus infection in German blood donors. J. Clin. Microbiol. 50:2708-2713. http://dx.doi.org /10.1128/JCM.01119-12.
144. Slot E, Hogema B, Riezebos-Brilman A, Kok T, Molier M, Zaaijer H. 2013. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill. 18:20550. http://www.eurosurveillance.org/View Article.aspx?ArticleId_20550.
145. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW, Ng MH, Zhang J, Xia NS. 2010. Prevalence of hepatitis E virus in Chinese blood donors. J. Clin. Microbiol. 48:317-318. http://dx.doi.org/10.1128/JCM.01466-09.
146. Yunoki M, Yamamoto S, Tanaka H, Nishigaki H, Tanaka Y, Nishida A, Adan-Kubo J, Tsujikawa M, Hattori S, Urayama T, Yoshikawa M, Yamamoto I, Hagiwara K, Ikuta K. 2008. Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters. Vox Sang. 95:94-100. http://dx.doi.org/10.1111/j.1423-0410.2008.01078.x.
147. Meng XJ, Anderson D, Arankalle VA, Emerson SU, Harrison TJ, Jameel S, Okamoto H (ed). 2012. Hepeviridae. Elsevier, San Diego, CA.
148. Payne CJ, Ellis TM, Plant SL, Gregory AR, Wilcox GE. 1999. Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus. Vet. Microbiol. 68:119-125. http://dx.doi.org /10.1016/S0378-1135(99)00067-X.
149. Batts W, Yun S, Hedrick R, Winton J. 2011. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res. 158:116-123. http://dx.doi.org/10.1016/j.virusres.2011.03.019.
150. Smith DB, Purdy MA, Simmonds P. 2013. Genetic variability and the classification of hepatitis E virus. J. Virol. 87:4161-4169. http://dx.doi.org/10.1128/JVI.02762-12.
151. Takahashi M, Nishizawa T, Sato H, Sato Y, Jirintai Nagashima S, Okamoto H. 2011. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J. Gen. Virol. 92:902-908. http://dx.doi.org/10.1099/vir.0.029470-0.
152. Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, Fan J, Ma H, Li M, Song A, Wang Y. 2009. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J. Med. Virol. 81:1371-1379. http://dx.doi.org/10.1002/jmv.21536.
153. Meng XJ. 2013. Zoonotic and foodborne transmission of hepatitis E virus. Semin. Liver Dis. 33:41-49. http://dx.doi.org/10.1055/s-0033-1338113.
154. Oliveira-Filho EF, Konig M, Thiel HJ. 2013. Genetic variability of HEV isolates: inconsistencies of current classification. Vet. Microbiol. 165: 148-154. http://dx.doi.org/10.1016/j.vetmic.2013.01.026.
155. Purdy MA, Khudyakov YE. 2011. The molecular epidemiology of hepatitis E virus infection. Virus Res. 161:31-39. http://dx.doi.org/10.1016/j.virusres.2011.04.030.
156. Legrand-Abravanel F, Mansuy JM, Dubois M, Kamar N, Peron JM, Rostaing L, Izopet J. 2009. Hepatitis E virus genotype 3 diversity, France. Emerg. Infect. Dis. 15:110-114. http://dx.doi.org/10.3201/eid1501.080296.
157. Bouquet J, Tesse S, Lunazzi A, Eloit M, Rose N, Nicand E, Pavio N. 2011. Close similarity between sequences of hepatitis E virus recovered from humans and swine, France, 2008-2009. Emerg. Infect. Dis. 17: 2018-2025. http://dx.doi.org/10.3201/eid1711.110616.
158. Nakano T, Takahashi K, Arai M, Okano H, Kato H, Ayada M, Okamoto H, Mishiro S. 2013. Identification of European-type hepatitis E virus subtype 3e isolates in Japanese wild boars: molecular tracing of HEV from swine to wild boars. Infect. Genet. Evol. 18:287-298. http://dx.doi.org/10.1016/j.meegid.2013.06.004.
159. Fu H, Li L, Zhu Y, Wang L, Geng J, Chang Y, Xue C, Du G, Li Y, Zhuang H. 2010. Hepatitis E virus infection among animals and humans in Xinjiang, China: possibility of swine to human transmission of sporadic hepatitis E in an endemic area. Am. J. Trop. Med. Hyg. 82:961-966. http://dx.doi.org/10.4269/ajtmh.2010.09-0689.
160. Norder H, Sundqvist L, Magnusson L, Ostergaard Breum S, Lofdahl M, Larsen LE, Hjulsager CK, Magnius L, Bottiger BE, Widen F. 2009. Endemic hepatitis E in two Nordic countries. Euro Surveill. 14:19211. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19211.
161. Zhang W, Yang S, Ren L, Shen Q, Cui L, Fan K, Huang F, Kang Y, Shan T, Wei J, Xiu H, Lou Y, Liu J, Yang Z, Zhu J, Hua X. 2009. Hepatitis E virus infection in central China reveals no evidence of crossspecies transmission between human and swine in this area. PLoS One 4:e8156. http://dx.doi.org/10.1371/journal.pone.0008156.
162. Arankalle VA, Chobe LP, Joshi MV, Chadha MS, Kundu B, Walimbe AM. 2002. Human and swine hepatitis E viruses from Western India belong to different genotypes. J. Hepatol. 36:417-425. http://dx.doi.org /10.1016/S0168-8278(01)00297-5.
163. Shukla P, Chauhan UK, Naik S, Anderson D, Aggarwal R. 2007. Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J. Viral Hepat. 14:310-317. http://dx.doi.org /10.1111/j.1365-2893.2006.00815.x.
164. Purdy MA, Dell'Amico MC, Gonzales JL, Segundo H, Tolari F, Mazzei M, Bartoloni A, Khudyakov YE. 2012. Human and porcine hepatitis E viruses, southeastern Bolivia. Emerg. Infect. Dis. 18:339-340. http://dx.doi.org/10.3201/eid1802.111453.
165. Cossaboom CM, Cordoba L, Cao D, Ni YY, Meng XJ. 2012. Complete genome sequence of hepatitis E virus from rabbits in the United States. J. Virol. 86:13124-13125. http://dx.doi.org/10.1128/JVI.02414-12.
166. Lhomme S, Dubois M, Abravanel F, Top S, Bertagnoli S, Guerin JL, Izopet J. 2013. Risk of zoonotic transmission of HEV from rabbits. J. Clin. Virol. 58:357-362. http://dx.doi.org/10.1016/j.jcv.2013.02.006.
167. Purdy MA, Khudyakov YE. 2010. Evolutionary history and population dynamics of hepatitis E virus. PLoS One 5:e14376. http://dx.doi.org/10.1371/journal.pone.0014376.
168. Dai X, Dong C, Zhou Z, Liang J, Dong M, Yang Y, Fu J, Tian H, Wang S, Fan J, Meng J, Purdy MA. 2013. Hepatitis E virus genotype 4, Nanjing, China, 2001-2011. Emerg. Infect. Dis. 19:1528-1530. http://dx.doi.org/10.3201/eid1909.130013.
169. Ma Z, Feng R, Zhao C, Harrison TJ, Li M, Qiao Z, Feng Y, Wang Y. 2010. Seroprevalence and distribution of hepatitis E virus in various ethnic groups in Gansu Province, China. Infect. Genet. Evol. 10:614-619. http://dx.doi.org/10.1016/j.meegid.2010.04.003.
170. Yu Y, Sun J, Liu M, Xia L, Zhao C, Harrison TJ, Wang Y. 2009. Seroepidemiology and genetic characterization of hepatitis E virus in the northeast of China. Infect. Genet. Evol. 9:554-561. http://dx.doi.org/10.1016/j.meegid.2009.02.008.
171. Emerson SU, Clemente-Casares P, Moiduddin N, Arankalle VA, Torian U, Purcell RH. 2006. Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay. J. Gen. Virol. 87:697-704. http://dx.doi.org/10.1099/vir.0.81545-0.
172. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH. 2002. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J. Clin. Microbiol. 40:4576-4580. http://dx.doi.org/10.1128/JCM.40.12.4576-4580.2002.
173. Huang S, Zhang X, Jiang H, Yan Q, Ai X, Wang Y, Cai J, Jiang L, Wu T, Wang Z, Guan L, Shih JW, Ng MH, Zhu F, Zhang J, Xia N. 2010. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 5:e13560. http://dx.doi.org/10.1371/journal.pone.0013560.
174. Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. 1993. Hepatitis E and long-term antibody status. Lancet 341:1355. http://dx.doi.org/10.1016/0140-6736(93)90873-F.
175. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, Kamili S, Teo CG. 2010. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin. Infect. Dis. 51:e24-e27. http://dx.doi.org/10.1086/654801.
176. Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F, Peron JM, Kamar N, Rostaing L, Izopet J. 2009. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin. Vaccine Immunol. 16:772-774. http://dx.doi.org/10.1128/CVI.00438-08.
177. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, Rosa I, Kamar N, Izopet J. 4 November 2013. Performance of anti-HEV assays for diagnosis of acute hepatitis E in immunocompromised patients. J. Clin. Virol. [Epub ahead of print.] http://dx.doi.org/10.1016/j.jcv.2013.10.003.
178. Chen HY, Lu Y, Howard T, Anderson D, Fong PY, Hu WP, Chia CP, Guan M. 2005. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin M antibodies to hepatitis E virus in human sera. Clin. Diagn. Lab. Immunol. 12:593-598. http://dx.doi.org/10.1128/CDLI.12.5.593-598.2005.
179. Myint KS, Guan M, Chen HY, Lu Y, Anderson D, Howard T, Noedl H, Mammen MP, Jr. 2005. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am. J. Trop. Med. Hyg. 73:942-946.
180. Ferguson M, Walker D, Mast E, Fields H. 2002. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 30:43-48. http://dx.doi.org/10.1006/biol.2001.0315.
181. Mast EE, Alter MJ, Holland PV, Purcell RH. 1998. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 27:857-861.
182. Schnegg A, Burgisser P, Andre C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KE. 2013. An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. PLoS One 8:e62980. http://dx.doi.org/10.1371/journal.pone.0062980.
183. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. 2013. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J. Infect. Dis. 207:497-500. http: //dx.doi.org/10.1093/infdis/jis688.
184. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. 2010. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J. Med. Virol. 82: 799-805. http://dx.doi.org/10.1002/jmv.21656.
185. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J. Med. Virol. 80:95-101. http://dx.doi.org/10.1002/jmv.21033.
186. Mansuy JM, Peron JM, Bureau C, Alric L, Vinel JP, Izopet J. 2004. Immunologically silent autochthonous acute hepatitis E virus infection in France. J. Clin. Microbiol. 42:912-913. http://dx.doi.org/10.1128 /JCM.42.2.912-913.2004.
187. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, Reche H, Destruel F, Kamar N, Dalton H, Izopet J. 2011. Hepatitis E virus antibody in blood donors, France. Emerg. Infect. Dis. 17:2309-2312.
188. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. 2011. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg. Infect. Dis. 17:30-37. http://dx.doi.org/10.3201/eid1701.100527.
189. Innis BL, Seriwatana J, Robinson RA, Shrestha MP, Yarbough PO, Longer CF, Scott RM, Vaughn DW, Myint KS. 2002. Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay. Clin. Diagn. Lab. Immunol. 9:639-648. http://dx.doi.org/10.1128/CDLI.9.3.639-648.2002.
190. Shrestha MP, Scott RM, Joshi DM, Mammen MP, Jr, Thapa GB, Thapa N, Myint KS, Fourneau M, Kuschner RA, Shrestha SK, David MP, Seriwatana J, Vaughn DW, Safary A, Endy TP, Innis BL. 2007. Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 356:895-903. http://dx.doi.org/10.1056/NEJMoa061847.
191. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. 2010. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895-902. http://dx.doi.org/10.1016/S0140-6736(10)61030-6.
192. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. 2007. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin. Vaccine Immunol. 14: 562-568. http://dx.doi.org/10.1128/CVI.00231-06.
193. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. 2012. Genotype 3 diversity and quantification of hepatitis E virus RNA. J. Clin. Microbiol. 50:897-902. http://dx.doi.org/10.1128 /JCM.05942-11.
194. Baylis SA, Hanschmann KM, Blumel J, Nubling CM. 2011. Standardization of hepatitis E virus (HEV) nucleic acid amplification techniquebased assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J. Clin. Microbiol. 49:1234-1239. http://dx.doi.org/10.1128/JCM.02578-10.
195. Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. 2013. Performance of two commercial assays for detecting hepatitis E virusRNAin acute or chronic infections. J. Clin. Microbiol. 51:1913-1916. http://dx.doi.org/10.1128 /JCM.00661-13.
196. Baylis SA, Blumel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nubling CM, Hanschmann KM. 2013. World Health Organization international standard to harmonize assays for detection of hepatitis E virus RNA. Emerg. Infect. Dis. 19:729-735. http://dx.doi.org/10.3201 /eid1905.121845.
197. Lan X, Yang B, Li BY, Yin XP, Li XR, Liu JX. 2009. Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus. J. Clin. Microbiol. 47:2304-2306. http://dx.doi.org/10.1128/JCM.00498-09.
198. Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. 2013. How should hepatitis E virus infection be defined in organ-transplant recipients? Am. J. Transplant. 13:1935-1936. http://dx.doi.org/10.1111/ajt.12253.
199. Howard CM, Handzel T, Hill VR, Grytdal SP, Blanton C, Kamili S, Drobeniuc J, Hu D, Teshale E. 2010. Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am. J. Trop. Med. Hyg. 83:1170-1173. http://dx.doi.org/10.4269/ajtmh.2010.10-0384.
200. Centers for Disease Control and Prevention. 2013. Investigation of hepatitis E outbreak among refugees-upper Nile, South Sudan, 2012-2013. MMWR Morb. Mortal. Wkly. Rep. 62:581-586.
201. Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, Purcell RH. 1995. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J. Infect. Dis. 171:447-450. http://dx.doi.org/10.1093/infdis/171.2.447.
202. Abe K, Li TC, Ding X, Win KM, Shrestha PK, Quang VX, Ngoc TT, Taltavull TC, Smirnov AV, Uchaikin VF, Luengrojanakul P, Gu H, El-Zayadi AR, Prince AM, Kikuchi K, Masaki N, Inui A, Sata T, Takeda N. 2006. International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J. Trop. Med. Public Health 37:90-95.
203. Fix AD, Abdel-Hamid M, Purcell RH, Shehata MH, Abdel-Aziz F, Mikhail N, el Sebai H, Nafeh M, Habib M, Arthur RR, Emerson SU, Strickland GT. 2000. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am. J. Trop. Med. Hyg. 62:519-523.
204. Echevarria JM, Gonzalez JE, Lewis-Ximenez LL, Dos Santos DR, Munne MS, Pinto MA, Pujol FH, Rodriguez-Lay LA. 2013. Hepatitis E virus infection in Latin America: a review. J. Med. Virol. 85:1037-1045. http://dx.doi.org/10.1002/jmv.23526.
205. Passos AM, Heringer TP, Medina-Pestana JO, Ferraz ML, Granato CF. 2013. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil. J. Med. Virol. 85:615-619. http://dx.doi.org/10.1002/jmv.23494.
206. Mirazo S, Ramos N, Russi JC, Arbiza J. 2013. Genetic heterogeneity and subtyping of human hepatitis E virus isolates from Uruguay. Virus Res. 173:364-370. http://dx.doi.org/10.1016/j.virusres.2013.01.005.
207. Garcia CG, Sanchez D, Villalba MC, Pujol FH, de Los Angeles Rodriguez Lay L, Pinto B, Chacon EP, Guzman MG. 2012. Molecular characterization of hepatitis E virus in patients with acute hepatitis in Venezuela. J. Med. Virol. 84:1025-1029. http://dx.doi.org/10.1002/jmv.23277.
208. Gardinali NR, Barry AF, Otonel RA, Alfieri AF, Alfieri AA. 2012. Hepatitis E virus in liver and bile samples from slaughtered pigs of Brazil. Mem. Inst. Oswaldo Cruz 107:935-939. http://dx.doi.org/10.1590/S0074-02762012000700016.
209. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. 1997. Severe hepatitis E infection during pregnancy. J. Viral Hepat. 4:51-54.
210. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, Novak RT, Sharapov UM, Tohme RA, Teshale E, Kamili S, Teo CG. 2013. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg. Infect. Dis. 19:218-222. http://dx.doi.org/10.3201/eid1902.120961.
211. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, Vischi F, Alric L, Vinel JP, Izopet J. 2004. Hepatitis E in the southwest of France in individuals who have never visited an endemic area. J. Med. Virol. 74:419-424. http://dx.doi.org/10.1002/jmv.20206.
212. Mitsui T, Tsukamoto Y, Hirose A, Suzuki S, Yamazaki C, Masuko K, Tsuda F, Endo K, Takahashi M, Okamoto H. 2006. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J. Med. Virol. 78:1015-1024. http://dx.doi.org/10.1002/jmv.20657.
213. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H, Destruel F, Izopet J. 2008. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J. Med. Virol. 80:289-293. http://dx.doi.org/10.1002/jmv.21056.
214. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. 2007. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J. Clin. Microbiol. 45:2009-2010. http://dx.doi.org/10.1128/JCM.00235-07.
215. Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S. 2011. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang. 100:340-342. http://dx.doi.org/10.1111/j.1423-0410.2010.01412.x.
216. Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, Scobie L, Petrik J. 2013. Hepatitis E virus in Scottish blood donors. Vox Sang. 105:283-289. http://dx.doi.org/10.1111/vox.12056.
217. Faramawi MF, Johnson E, Chen S, Pannala PR. 2011. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol. Infect. 139:1145-1150. http://dx.doi.org/10.1017/S0950268810002177.
218. Dalton HR, Bendall RP, Rashid M, Ellis V, Ali R, Ramnarace R, Stableforth W, Headdon W, Abbott R, McLaughlin C, Froment E, Hall KJ, Michell NP, Thatcher P, Henley WE. 2011. Host risk factors and autochthonous hepatitis E infection. Eur. J. Gastroenterol. Hepatol. 23: 1200-1205. http://dx.doi.org/10.1097/MEG.0b013e32834ca4da.
219. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, Dalton HR, Harrison TJ, Hill SF, Macfarlane L, Meigh RE, Shafi S, Sheppard MJ, Smithson J, Wilson MP, Teo CG. 2005. Non-travelassociated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J. Infect. Dis. 192:1166-1172. http://dx.doi.org/10.1086/444396.
220. Madden RG, Hunter JG, Stone AM, Thornton C, Barlow M, Lewis H. 2012. Locally acquired hepatitis E. Geographical clustering and environmental factors: a nested case control study. J. Hepatol. 56(Suppl 2):s64. http://dx.doi.org/10.1016/S0168-8278(12)60161-5.
221. Ishida S, Yoshizumi S, Ikeda T, Miyoshi M, Goto A, Matsubayashi K, Ikeda H. 2012. Detection and molecular characterization of hepatitis E virus in clinical, environmental and putative animal sources. Arch. Virol. 157:2363-2368. http://dx.doi.org/10.1007/s00705-012-1422-8.
222. de Niet A, Zaaijer HL, Ten Berge I, Weegink CJ, Reesink HW, Beuers U. 2012. Chronic hepatitis E after solid organ transplantation. Neth. J. Med. 70:261-266.
223. Gerolami R, Moal V, Colson P. 2008. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N. Engl. J. Med. 358:859-860. http://dx.doi.org/10.1056/NEJMc0708687.
224. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP. 2008. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 14:547-553. http://dx.doi.org/10.1002/lt.21480.
225. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. 2011. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140: 1481-1489. http://dx.doi.org/10.1053/j.gastro.2011.02.050.
226. Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ, Osterhaus AD, van der Eijk AA. 2013. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J. Heart Lung Transplant. 32:78-85. http://dx.doi.org/10.1016/j.healun.2012.10.008.
227. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, Ganzenmueller T, Schlue J, Horn-Wichmann R, Raupach R, Darnedde M, Scheibner Y, Taubert R, Haverich A, Manns MP, Wedemeyer H, Bara CL. 2012. Chronic hepatitis E in heart transplant recipients. Am. J. Transplant. 12:3128-3133. http://dx.doi.org/10.1111/j.1600-6143.2012.04200.x.
228. Te HS, Drobeniuc J, Kamili S, Dong C, Hart J, Sharapov UM. 2013. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant. Proc. 45:810-813. http://dx.doi.org/10.1016/j.transproceed.2012.08.020.
229. Dalton HR, Bendall R, Keane F, Tedder R, Ijaz S. 2009. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361:1025-1027. http://dx.doi.org/10.1056/NEJMc0903778.
230. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet J, Nicand E. 2009. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann. Intern. Med. 150:430-431.
231. Khuroo MS, Kamili S, Yattoo GN. 2004. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J. Gastroenterol. Hepatol. 19:778-784. http://dx.doi.org/10.1111/j.1440-1746.2004.03437.x.
232. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, Nishizawa T, Okamoto H. 2004. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J. Med. Virol. 74:563-572. http://dx.doi.org/10.1002/jmv.20215.
233. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, Mishiro S, Shimizu K, Moriyama M. 2007. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol. Res. 37:113-120. http://dx.doi.org/10.1111/j.1872-034X.2007.00024.x.
234. Coilly A, Haim-Boukobza S, Roche B, Antonini TM, Pause A, Mokhtari C, Becq A, Farahmand H, Hauser L, Duclos-Vallee JC, Samuel D, Adam R, Roque-Afonso AM. 2013. Posttransplantation hepatitis E: transfusiontransmitted hepatitis rising from the ashes. Transplantation 96:e4-e6. http: //dx.doi.org/10.1097/TP.0b013e318296c9f7.
235. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Kruger DH, Berg T, Hofmann J. 2012. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J. Hepatol. 56:500-502. http://dx.doi.org/10.1016/j.jhep.2011.06.021.
236. Buti M, Cabrera C, Jardi R, Castells L, Esteban R. 2010. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl. 16:106-107. http://dx.doi.org/10.1002/lt.21925.
237. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, Reimerink JH, Koopmans MP. 2009. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 15:1225-1228. http://dx.doi.org/10.1002/lt.21819.
238. Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gerolami R, Berland Y, Colson P. 2013. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J. Med. Virol. 85:462-471. http://dx.doi.org/10.1002/jmv.23469.
239. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, Koopmans MP, Osterhaus AD, van der Eijk AA. 2012. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg. Infect. Dis. 18:869-872. http://dx.doi.org/10.3201/eid1805.111712.
240. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H. 2010. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 16:74-82. http://dx.doi.org/10.1002/lt.21958.
241. Riezebos-Brilman A, Puchhammer-Stöckl E, Van der Weide H, Haagsma EB, Jaksch P, Bejvl I, Niesters HG, Verschuuren EA. 2013. Chronic hepatitis E infection in lung transplant recipients. J. Heart Lung Transplant. 32:341-346. http://dx.doi.org/10.1016/j.healun.2012.11.027.
242. Moal V, Motte A, Kaba M, Gerolami R, Berland Y, Colson P. 2013. Hepatitis E virus serological testing in kidney transplant recipients with elevated liver enzymes in 2007-2011 in southeastern France. Diagn. Microbiol. Infect. Dis. 76:116-118. http://dx.doi.org/10.1016/j.diagmicrobio.2013.02.017.
243. Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, Alvarez F. 2012. Chronic hepatitis E infection in children with liver transplantation. Gut 64:597-603. http://dx.doi.org/10.1136/gutjnl-2011-300708.
244. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L. 2010. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 89:353-360. http://dx.doi.org/10.1097/TP.0b013e3181c4096c.
245. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, Otal P, Esposito L, Durand D, Izopet J, Rostaing L. 2008. Hepatitis E virus-related cirrhosis in kidney-and kidney-pancreas-transplant recipients. Am. J. Transplant. 8:1744-1748. http://dx.doi.org/10.1111/j.1600-6143.2008.02286.x.
246. Kamar N, Izopet J, Rostaing L. 2012. No reactivation of hepatitis E virus after kidney retransplantation. Am. J. Transplant. 12:507-508. http://dx.doi.org/10.1111/j.1600-6143.2011.03838.x.
247. Lhomme S, Abravanel F, Dubois M, Sandres Saune K, Rostaing L, Kamar N, Izopet J. 2012. HEV quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J. Virol. 86:10006-10014. http://dx.doi.org/10.1128/JVI.01003-12.
248. Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert AA, Bremer B, Markova A, Jaroszewicz J, Bara C, Manns M, Cornberg M, Wedemeyer H. 2012. HEV-specific T-cell responses are associated with control ofHEVinfection. Hepatology 55:695-708. http://dx.doi.org /10.1002/hep.24738.
249. Kamar N, Legrand-Abravanel F, Dalton HR, Izopet J. 2012. Hepatitis E virus-specific T-cell response after transplantation. Hepatology 55: 1643. http://dx.doi.org/10.1002/hep.25578.
250. Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J. Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. J. Infect. Dis., in press.
251. Moal V, Textoris J, Ben Amara A, Mehraj V, Berland Y, Colson P, Mege JL. 2013. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. J. Infect. Dis. 207:125-132. http://dx.doi.org/10.1093/infdis/jis632.
252. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S. 2012. Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology 55:1324-1332. http://dx.doi.org/10.1002/hep.25530.
253. Hoerning A, Hegen B, Wingen AM, Cetiner M, Lainka E, Kathemann S, Fiedler M, Timm J, Wenzel JJ, Hoyer PF, Gerner P. 2012. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients-a single-center experience. Pediatr. Transplant. 16:742-747. http: //dx.doi.org/10.1111/j.1399-3046.2012.01740.x.
254. Junge N, Pischke S, Baumann U, Goldschimdt I, Manns M, Wedemeyer H, Pfister E. 2013. Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr. Transplant. 17:343-347. http://dx.doi.org/10.1111/petr.12077.
255. Motte A, Roquelaure B, Galambrun C, Bernard F, Zandotti C, Colson P. 2012. Hepatitis E in three immunocompromised children in southeast France. J. Clin. Virol. 53:162-166. http://dx.doi.org/10.1016/j.jcv.2011.11.012.
256. Crum-Cianflone NF, Curry J, Drobeniuc J, Weintrob A, Landrum M, Ganesan A, Bradley W, Agan BK, Kamili S. 2012. Hepatitis E virus infection in HIV-infected persons. Emerg. Infect. Dis. 18:502-506. http: //dx.doi.org/10.3201/eid1803.111278.
257. Jardi R, Crespo M, Homs M, van den Eynde E, Girones R, Rodriguez-Manzano J, Caballero A, Buti M, Esteban R, Rodriguez-Frias F. 2012. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med. 13:379-383. http://dx.doi.org/10.1111/j.1468-1293.2011.00985.x.
258. Kaba M, Richet H, Ravaux I, Moreau J, Poizot-Martin I, Motte A, Nicolino-Brunet C, Dignat-George F, Menard A, Dhiver C, Brouqui P, Colson P. 2011. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J. Med. Virol. 83:1704-1716. http://dx.doi.org/10.1002/jmv.22177.
259. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, Black J, Baragwanath G, Lin N, Henley W, Ngui SL, Ijaz S, Dalton H. 2012. Hepatitis E virus coinfection in patients with HIV infection. HIV Med. 13:83-88. http://dx.doi.org/10.1111/j.1468-1293.2011.00942.x.
260. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, Witteck A, Darling KE, Kovari H, Kaiser L, Evison JM, Elzi L, Gurter-De La Fuente V, Jost J, Moradpour D, Abravanel F, Izopet J, Cavassini M. 2011. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg. Infect. Dis. 17:1074-1078. http://dx.doi.org/10.3201/eid /1706.101067.
261. Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, Nicand E, Simon F, Delaugerre C. 2012. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. J. Clin. Virol. 53:346-349. http://dx.doi.org/10.1016/j.jcv.2012.01.001.
262. Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP, Stoll M, Wedemeyer H. 2010. Hepatitis E in HIV-positive patients in a low-endemic country. J. Viral Hepat. 17:598-599. http://dx.doi.org /10.1111/j.1365-2893.2009.01219.x.
263. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allegre T, Poggi C, Penaranda G, Cordier F, Nicand E. 2010. Hepatitis E virus in HIV-infected patients. AIDS 24:1493-1499. http://dx.doi.org/10.1097 /QAD.0b013e32833a29ab.
264. Sellier P, Mazeron MC, Tesse S, Badsi E, Evans J, Magnier JD, Sanson-Le-Pors MJ, Bergmann JF, Nicand E. 2011. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels. Virol. J. 8:171. http://dx.doi.org/10.1186/1743-422X-8-171.
265. van Welzen BJ, Verduyn Lunel FM, Meindertsma F, Hoepelman AI, Arends JE. 2012. Hepatitis E virus as a causative agent of unexplained liver enzyme elevations in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 60:e65-e67. http://dx.doi.org/10.1097/QAI.0b013e318251b01f.
266. Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V. 2009. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J. Viral Hepat. 16:895-896. http://dx.doi.org/10.1111/j.1365-2893.2009.01138.x.
267. Andersson MI, Preiser W, Maponga TG, Heys I, Taljaard JJ, van Rensburg C, Tedder RS, Ijaz S. 2013. Immune reconstitution hepatitis E: a neglected complication of antiretroviral therapy in Africa? AIDS 27:487-489. http://dx.doi.org/10.1097/QAD.0b013e32835b1074.
268. Colson P, Dhiver C, Gerolami R. 2008. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin. Microbiol. Infect. 14:1176-1180. http://dx.doi.org /10.1111/j.1469-0691.2008.02102.x.
269. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gerolami R. 2011. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J. Viral Hepat. 18:227-228. http://dx.doi.org/10.1111/j.1365-2893.2010.01311.x.
270. Colson P, Gerolami R, Moreau J, Borentain P, Brouqui P. 2009. Concurrent autochthonous acute hepatitis E and hepatitis B reverse seroconversion in an HIV-1-infected patient: one virus may hide another. Int. J. Infect. Dis. 14:e357. http://dx.doi.org/10.1016/j.ijid.2009.04.007.
271. Colson P, Kaba M, Moreau J, Brouqui P. 2009. Hepatitis E in an HIV-infected patient. J. Clin. Virol. 45:269-271. http://dx.doi.org/10.1016/j.jcv.2009.06.002.
272. Curry JA, Adams N, Crum-Cianflone NF. 2009. Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann. Intern. Med. 150:226-227. http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00028.
273. Hajji H, Gerolami R, Solas C, Moreau J, Colson P. 2013. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int. J. Antimicrob. Agents 41:595-597. http://dx.doi.org/10.1016/j.ijantimicag.2013.02.005.
274. Jagjit Singh GK, Ijaz S, Rockwood N, Farnworth SP, Devitt E, Atkins M, Tedder R, Nelson M. 2012. Chronic hepatitis E virus as a cause of cryptogenic cirrhosis in HIV. J. Infect. 66:103-106.
275. Nguyen HT, Torian U, Faulk K, Mather K, Engle RE, Thompson E, Bonkovsky HL, Emerson SU. 2012. A naturally occurring human/ hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J. Gen. Virol. 93:526-530. http://dx.doi.org/10.1099/vir.0.037259-0.
276. Payne BA, Medhi M, Ijaz S, Valappil M, Savage EJ, Gill ON, Tedder R, Schwab U. 2013. Hepatitis E virus seroprevalence among men who have sex with men, United Kingdom. Emerg. Infect. Dis. 19:333-335. http://dx.doi.org/10.3201/eid1902.121174.
277. Kaba M, Brouqui P, Richet H, Badiaga S, Gallian P, Raoult D, Colson P. 2010. Hepatitis E virus infection in sheltered homeless persons, France. Emerg. Infect. Dis. 16:1761-1763. http://dx.doi.org/10.3201 /eid1611.091890.
278. Larrat S, Gaillard S, Baccard M, Piroth L, Cacoub P, Pol S, Perronne C, Carrat F, Morand P. 2012. Hepatitis E virus infection in sheltered homeless persons, France. Emerg. Infect. Dis. 18:1031. http://dx.doi.org /10.3201/eid1806.110632.
279. Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N. 2011. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am. J. Gastroenterol. 106:1562-1563. http://dx.doi.org/10.1038 /ajg.2011.158.
280. Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. 2010. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-{ alpha} therapy. Ann. Intern. Med. 153:135-136. http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00256.
281. Gauss A, Wenzel JJ, Flechtenmacher C, Navid MH, Eisenbach C, Jilg W, Stremmel W, Schnitzler P. 2012. Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report. J. Med. Case Rep. 6:334. http://dx.doi.org/10.1186/1752-1947-6-334.
282. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tesse S, Thervet E, Mouthon L, Sogni P, Pol S. 2010. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann. Intern. Med. 153:85-89. http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00257.
283. Peron JM, Mansuy JM, Recher C, Bureau C, Poirson H, Alric L, Izopet J, Vinel JP. 2006. Prolonged hepatitis E in an immunocompromised patient. J. Gastroenterol. Hepatol. 21:1223-1224. http://dx.doi.org/10.1111/j.1440-1746.2006.04209.x.
284. Tavitian S, Peron JM, Huynh A, Mansuy JM, Ysebaert L, Huguet F, Vinel JP, Attal M, Izopet J, Recher C. 2010. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J. Clin. Virol. 49:141-144. http://dx.doi.org/10.1016/j.jcv.2010.06.016.
285. Knoenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz R, Schulz T, Manns MP, Ganser A, Wedemeyer H. 2012. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transplant. Infect. Dis. 14:103-106. http://dx.doi.org/10.1111/j.1399-3062.2011.00702.x.
286. Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J. 2012. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J. Clin. Virol. 54:152-155. http://dx.doi.org/10.1016/j.jcv.2012.02.015.
287. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA. 2013. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122:1079-1086. http://dx.doi.org/10.1182/blood-2013-03-492363.
288. Halac U, Beland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, Alvarez F. 2012. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J. Pediatr. 160:871-874. http://dx.doi.org /10.1016/j.jpeds.2012.01.028.
289. le Coutre P, Meisel H, Hofmann J, Rocken C, Vuong GL, Neuburger S, Hemmati PG, Dorken B, Arnold R. 2009. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 58:699-702. http://dx.doi.org/10.1136 /gut.2008.165571.
290. Pfefferle S, Frickmann H, Gabriel M, Schmitz N, Gunther S, Schmidt-Chanasit J. 2012. Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection 40:451-454. http://dx.doi.org/10.1007/s15010-011-0220-7.
291. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, Mansuy JM, Selves J, Peron JM, Otal P, Muscari F, Izopet J. 2010. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin. Infect. Dis. 50:e30-e33. http: //dx.doi.org/10.1086/650488.
292. Kamar N, Abravanel F, Garrouste C, Cardeau-Desangles I, Mansuy JM, Weclawiak H, Izopet J, Rostaing L. 2010. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol. Dial. Transplant. 25:2792-2795. http: //dx.doi.org/10.1093/ndt/gfq282.
293. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. 2010. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl. 16:474-477. http://dx.doi.org/10.1002/lt.22014.
294. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. 1995. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59:1426-1431. http://dx.doi.org/10.1097/00007890-199505270-00012.
295. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A. 2011. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J. Heart Lung Transplant. 30: 841-843. http://dx.doi.org/10.1016/j.healun.2011.03.013.
296. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, Alric L, Peron JM, Izopet J. 2010. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 139:1612-1618. http://dx.doi.org/10.1053/j.gastro.2010.08.002.
297. Pischke S, Hardkte S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, Bara C, Glottlieb J, Wenzel JJ, Manns M, Wedemeyer H. 2013. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 33:722-726. http://dx.doi.org/10.1111/liv.12114.
298. Feld JJ, Hoofnagle JH. 2005. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 436:967-972. http://dx.doi.org/10.1038/nature04082.
299. Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. 2012. Hepatitis E virus: what transplant physicians should know. Am. J. Transplant. 12: 2281-2287. http://dx.doi.org/10.1111/j.1600-6143.2012.04078.x.
300. Neukam K, Barreiro P, Macias J, Avellon A, Cifuentes C, Martin-Carbonero L, Echevarria JM, Vargas J, Soriano V, Pineda JA. 2013. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin. Infect. Dis. 57:465-468. http://dx.doi.org/10.1093/cid/cit224.
301. Dalton H, Keane F, Bendall R, Mathew J, Ijaz S. 2011. Treatment of chronic hepatitis E in a HIV positive patient. Ann. Intern. Med. 155:479-480. http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00017.
302. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. 2011. Treatment of severe acute hepatitis E by ribavirin. J. Clin. Virol. 52:60-62. http://dx.doi.org/10.1016/j.jcv.2011.06.004.
303. Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. 2012. Ribavirin therapy for hepatitis E virus-induced acute or chronic liver failure: a preliminary report. Antivir. Ther. 17:1091-1096. http://dx.doi.org/10.3851/IMP2317.
304. Peron JM, Dalton H, Izopet J, Kamar N. 2011. Acute autochthonous hepatitis E in Western patients with underlying chronic liver disease: a role for ribavirin? J. Hepatol. 54:1323-1324. http://dx.doi.org/10.1016/j.jhep.2011.01.009.
305. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, Ge SX, Xian YL, Pang SQ, Ng MH, Xia NS. 2005. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivityonprimates. Vaccine 23:2893-2901. http://dx.doi.org/10.1016/j.vaccine.2004.11.064.
306. Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, Luo D, Pan BB, Nong Y, Ge SX, Xiong JH, Shih JW, Ng MH, Xia NS. 2009. Randomizedcontrolled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 27:1869-1874. http://dx.doi.org/10.1016/j.vaccine.2008.12.061.